Axsome Therapeutics (NASDAQ:AXSM) Raised to "Strong-Buy" at Cantor Fitzgerald - MarketBeat
3 hours ago • Google News
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
3 hours ago • Google News
4 weeks ago • Google News
2 weeks ago • Google News